Sedation cocktail shows promise for routine scopes

NCT ID NCT07604480

Completed Knowledge-focused Sponsor: University of Medicine and Pharmacy "Victor Babes" Timisoara Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study looked at whether a mix of two sedatives, remimazolam and propofol, works well and safely for people having a gastrointestinal endoscopy (a scope procedure). Researchers watched 29 adults during their procedure to see if the sedation was effective and how quickly they recovered. The goal was to gather information on safety and effectiveness for future use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: remimazolam and propofol combination
What this could lead to: If successful, this could point toward a safer and more effective sedation method for routine endoscopic procedures.
What could go wrong: This is a small, completed observational study with only 29 participants, so results may not apply to larger or more diverse groups. No major risks were highlighted, but sedation always carries some risk of breathing or heart problems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL ENDOSCOPY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTROINTESTINAL ENDOSCOPY PROCEDURAL SEDATION

Contacts and locations

Locations

"Pius Brînzeu" Emergency County Hospital

Timișoara, Timiș County, 300096, Romania

More trials for these conditions

Other studies related to the condition(s) this trial covers.